trans-3-Bromocinnamic Acid
CAS: 14473-91-7
Ref. 3D-FB164016
2g | Descatalogado | ||
5g | Descatalogado | ||
10g | Descatalogado | ||
25g | Descatalogado | ||
50g | Descatalogado |
Información del producto
- (2E)-3-(3-Bromophenyl)-2-propenoic acid
- (2E)-3-(3-bromophenyl)acrylic acid
- (2E)-3-(3-bromophenyl)prop-2-enoate
- (2E)-3-(3-bromophenyl)prop-2-enoic acid
- (2Z)-3-(3-bromophenyl)prop-2-enoic acid
- (E)-3-(3-Bromophenyl)acrylic acid
- (E)-3-Bromocinnamic acid
- (E)-m-Bromocinnamic acid
- 2-Propenoic acid, 3-(3-bromophenyl)-, (2E)-
- 2-Propenoic acid, 3-(3-bromophenyl)-, (E)-
- Ver más sinónimos
- 3-(3-Bromophenyl)Prop-2-Enoic Acid
- 3-Bromo-trans-cinnamic acid
- Bw-A 800U
- Cinnamic acid, m-bromo-, (E)-
- m-Bromocinnamic acid
- trans-3-(3-Bromophenyl)-2-propenoic acid
- trans-3-(3-Bromophenyl)acrylic acid
- trans-3-Bromocinnamic acid
- trans-m-Bromocinnamic acid
Trans-3-bromocinnamic acid is a molecule that inhibits the adenosine receptor. It also has been shown to have anti-inflammatory effects, which may be due to its ability to inhibit prostaglandin synthesis. Trans-3-Bromocinnamic acid has been studied as an antiretroviral agent in mice and is currently being investigated for its role in the treatment of chronic inflammatory diseases. This molecule has also been shown to inhibit cell growth and induce apoptosis by acting on the protein SIRT1. Trans-3-Bromocinnamic acid has not yet been tested in humans but animal studies indicate that it may be safe for use in long term treatments.